Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

1. G. Hoarau^a, 
2. P. K. Mukherjee^b, 
3. C. Gower-Rousseau^c, 
4. C. Hager^b, 
5. J. Chandra^b,
6. M. A. Retuerto^b, 
7. C. Neut^a, 
8. S. Vermeire^d, 
9. J. Clemente^e,^f, 
10. J. F. Colombel^c,^g, 
11. H. Fujioka^h,
12. D. Poulain^a, 
13. B. Sendid^a, 
14. M. A. Ghannoum^b

+Author Affiliations

1. aInserm U995-Team 2, Université Lille 2, Faculté de Médecine H. Warembourg, Pôle Recherche, CHRU de Lille, Lille, France
2. bCenter for Medical Mycology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA
3. cEpimad Registry, Epidemiology Unit and LIRIC Inserm 995, Lille University and Hospital, Lille, France
4. dDepartment of Gastroenterology, University Hospital Leuven, Leuven, Belgium
5. eDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
6. fImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
7. gDepartment of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
8. hEM Core Facility, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

1. Address correspondence to B. Sendid, bsendid@univ-lille2.fr, or M. A. Ghannoum,Mahmoud.Ghannoum@case.edu.

1. G.H. and P.K.M. contributed equally to the study.
2. Editor Robert A. Bonomo, Louis Stokes Veterans Affairs Medical Center

 

Next Section

ABSTRACT

Crohn’s disease (CD) results from a complex interplay between host genetic factors and endogenous microbial communities. In the current study, we used Ion Torrent sequencing to characterize the gut bacterial microbiota (bacteriome) and fungal community (mycobiome) in patients with CD and their nondiseased first-degree relatives (NCDR) in 9 familial clusters living in northern France-Belgium and in healthy individuals from 4 families living in the same area (non-CD unrelated [NCDU]).

Clinical Relevance of IgE to Profilin and/or Polcalcin in Pollen-Sensitized Patients

Editor's Choice -- Free Access

Int Arch Allergy Immunol 2016;169:101-107 

(DOI:10.1159/000444279)

San Nicoló M. · Braun T. · Eder K. · Berghaus A. · Gröger M. 

Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig Maximilian University Munich, Munich, Germany

Abstract

Background: Component-resolved diagnostics is gaining importance in allergy diagnostics. Allergen extracts contain components with different rates of prevalence and clinical relevance, which can be subdivided at molecular level into major and minor allergens.

Setting Occupational Exposure Limits for Chemical Allergens—Understanding the Challenges

• Journal List
• Taylor & Francis Open Select
• PMC4685595

Journal of Occupational and Environmental Hygiene

Taylor & Francis

J Occup Environ Hyg. 2015 Nov 25; 12(sup1): S82–S98.

Published online 2015 Nov 19. doi:  10.1080/15459624.2015.1072277

PMCID: PMC4685595

NIHMSID: NIHMS746362

G. S. Dotson, a , * A. Maier, a , b P. D. Siegel, c S. E. Anderson, c B. J. Green, c A. B. Stefaniak, d C. D. Codispoti, e and I. Kimber f

Author information ► Copyright and License information ►

Abstract

Chemical allergens represent a significant health burden in the workplace. Exposures to such chemicals can cause the onset of a diverse group of adverse health effects triggered by immune-mediated responses. Common responses associated with workplace exposures to low molecular weight (LMW) chemical allergens range from allergic contact dermatitis to life-threatening cases of asthma.

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®

Chandler, R.E., Juhlin, K., Fransson, J. et al. Drug Saf (2016). doi:10.1007/s40264-016-0456-3

Open Access

Abstract

Introduction

A number of safety signals—complex regional pain syndrome (CRPS), postural orthostatic tachycardia syndrome (POTS), and chronic fatigue syndrome (CFS)—have emerged with human papillomavirus (HPV) vaccines, which share a similar pattern of symptomatology. Previous signal evaluations and epidemiological studies have largely relied on traditional methodologies and signals have been considered individually.

Active treatment for food allergy

Aaron K. KobernickPress enter key for correspondence informationPress enter key to Email the author

, 

A. Wesley Burks

Open Access

DOI: http://dx.doi.org/10.1016/j.alit.2016.08.002

Article Info

• Abstract

• Full Text
• Images
• References

Abstract

Food allergy has grown in rapidly in prevalence, currently affecting 5% of adults and 8% of children. Management strategy is currently limited to 1) food avoidance and 2) carrying and using rescue intramuscular epinephrine/adrenaline and oral antihistamines in the case of accidental ingestion; there is no FDA approved treatment. Recently, oral, sublingual and epicutaneous immunotherapy have been developed as active treatment of food allergy, though none have completed phase 3 study.

Dr. Alan Goldsobel reviews the diagnosis and management of patients who have chronic cough

Dr. Alan Goldsobel reviews the diagnosis and management of patients who have chronic cough

ACAAICOLA

Dr. Maya Nanda describes how to do oral food challenges to evaluate food-allergic patients

Dr. Maya Nanda describes how to do oral food challenges to evaluate food-allergic patients
ACAAICOLA

Dr. Robbie Pesek discusses the basics of food allergy

Dr. Robbie Pesek discusses the basics of food allergy

ACAAICOLA